PRINCETON, N.J., March 18 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced today that Marc Kamin, M.D., has been appointed Vice President, Medical and Scientific Affairs, Neuroscience. Dr. Kamin will serve in an advisory role to clients in the area of neuroscience and will provide medical support to PharmaNet project teams conducting neuroscience clinical studies.
“We are delighted to have a physician of his caliber at the forefront of our neuroscience team,” commented Dr. Pablo Fernandez, Senior Vice President, Worldwide Medical Affairs. “Marc’s vast experience and valuable expertise strengthens our neuroscience service offering.”
PharmaNet’s already extensive neuroscience experience is based on the conduct of more than 160 neuroscience studies. With access to a large worldwide pool of neuroscience investigators, combined with in-house expertise and the appointments of industry-recognized experts, PharmaNet is well positioned for the conduct of neuroscience clinical development programs.
About PharmaNet Development Group, Inc.
PharmaNet Development Group, Inc.
